Boston Scientific receives FDA approval for Parkinson's implant
WBJ File Photo
Boston Scientific is expanding its Parkinson's implant in the U.S.
The U.S. Food & Drug Administration has approved a new brain-stimulation Parkinson's disease implant from Marlborough medical device manufacturer Boston Scientific, the company announced Monday.
The technology behind Boston Scientific's Deep Brain Stimulation System is based off cochlear implants, which stimulate auditory nerves to produce a sense of hearing. The new Parkinson's treatment uses eight leads in the brain to offset the symptoms of the disease by stimulating the brain in a more adaptable way.
The FDA approval was the result of a Boston Scientific study on the impact of the treatment, which examined 292 patients using the implant at 23 different sites across the U.S. The implant has been approved and used commercially in Europe since 2012.
Following the FDA approval, the first commercial treatment will be implanted in a patient at the University of Minnesota Medical Center in Minneapolis.
WBJ Web Partners
Most Recent
Most Recent
0 Comments